Acta Neurochirurgica

, Volume 131, Issue 3–4, pp 282–288 | Cite as

Involvement of protein kinase C in growth regulation of human meningioma cells

  • T. Todo
  • R. Fahlbusch
Experimental Research


In order to investigate the possible role of protein kinase C (PKC)-mediated signal pathways in growth regulation of meningiomas, we examined the effect of two PKC-activating phorbol esters, 12-O-tetradecanoyl-13-phorbol acetate (TPA) and phorbol 12, 13-dibutyrate (PDBu), and PKC inhibitor, staurosporine, on cell proliferation using low-passage human meningioma cells in culture. TPA (0.1 to 100 ng/ml) caused a dose-dependent stimulation of cell proliferation in six of eight meningioma cultures. At optimal concentrations of TPA, the cell growth ranged from 113% to 251% versus control. In contrast, PDBu (0.1 to 100 ng/ml) caused a significant inhibition of cell proliferation in three of five meningioma cultures. At optimal concentrations of PDBu, the cell growth ranged from 52% to 79% of control. Staurosporine exhibited a stimulation of cell proliferation (135% to 178%) in three of four meningioma cultures studied at a concentration of 10−10 to 10−9M, although a tendency of growth inhibition was observed at a lower concentration. A time course of DNA synthesis in response to TPA, assessed by [3H] thymidine incorporation studies, revealed a time- and dose-dependent stimulation and/or inhibition which further depended on the serum concentration of the growth medium used. The overall results indicate that PKC-mediated signal pathways are closely involved in growth regulation of human meningioma cells. The results further suggest that the signalling processes consist of complex mechanisms which await to be elucidated.


Meningioma brain neoplasm protein kinase C phorbol ester staurosporine 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Adams EF, Schrell UMH, Fahlbusch R, Thierauf P (1990) Hormonal dependency of cerebral meningiomas. Part 2: in vitro effect of steroids, bromocriptine, and epidermal growth factor on growth of meningiomas. J Neurosurg 73: 750–755PubMedGoogle Scholar
  2. 2.
    Adams EF, Todo T, Schrell UMH, Thierauf P, White MC, Fahlbusch R (1991) Autocrine control of human meningioma proliferation: secretion of platelet-derived growth factor-like molecules. Int J Cancer 49: 398–402PubMedGoogle Scholar
  3. 3.
    Adams JC, Gullick WJ (1989) Differences in phorbol-ester-induced down-regulation of protein kinase C between cell lines. Biochem J 257: 905–911PubMedGoogle Scholar
  4. 4.
    Akita Y, Ohno S, Yajima Y, Suzuki K (1990) Possible role of Ca2+-independent protein kinase C isozyme, nPKCε, in thyrotropin-releasing hormone-stimulated signal transduction: differential down-regulation of nPKCε in GH4C1 cells. Biochem Biophys Res Commun 172: 184–189PubMedGoogle Scholar
  5. 5.
    Ase K, Saito N, Shearman MS, Kikkawa U, Ono Y, Igarashi K, Tanaka C, Nishizuka Y (1988) Distinct cellular expression of ΒI- and ΒII-subspecies of protein kinase C in rat cerebellum. J Neurosci 8: 3850–3856PubMedGoogle Scholar
  6. 6.
    Ballester R, Rosen OM (1985) Fate of immunoprecipitable protein kinase C in GH3 cells treated with phorbol 12-myristate 13-acetate. J Biol Chem 260: 15194–15199PubMedGoogle Scholar
  7. 7.
    Benzil DL, Finkelstein SD, Epstein MH, Finch PW (1992) Expression Pattern of α-protein kinase C in human astrocytomas indicates a role in malignant progression. Cancer Res 52: 2951–2956PubMedGoogle Scholar
  8. 8.
    Bhat NR (1989) Role of protein kinase C in glial cell proliferation. J Neurosci Res 22: 20–27PubMedGoogle Scholar
  9. 9.
    Borner C, Eppenberger U, Wyss R, Babbro D (1988) continuous synthesis of two protein kinase C-related proteins after down-regulation by phorbol esters. Proc Natl Acad Sci USA 85: 2110–2114PubMedGoogle Scholar
  10. 10.
    Couldwell WT, Antel JP, Apuzzo MLJ, Yong VW (1990) Inhibition of growth of established human glioma cell lines by modulators of the protein kinase-C system. J Neurosurg 73: 594–600PubMedGoogle Scholar
  11. 11.
    Couldwell WT, Antel JP, Yong VW (1992) Protein kinase C activity correlates with the grwoth rate of malignant gliomas. Part II: effects of glioma mitogens and modulators of protein kinase C. Neurosurgery 31: 717–724PubMedGoogle Scholar
  12. 12.
    Couldwell WT, Uhm JH, Antel JP, Yong VW (1991) Enhanced protein kinase C activity correlates with the growth rate of malignant gliomas in vitro. Neurosurgery 29: 880–887PubMedGoogle Scholar
  13. 13.
    Housey GM, Johnson MD, Hsiao WLW, O'Brian CA, Murphy JP, Kirschmeier P, Weinstein IB (1988) Overproduction of protein kinase C causes disordered growth control in rat fibroblasts. Cell 52: 343–354PubMedGoogle Scholar
  14. 14.
    Huang FL, Yoshida Y, Cunha-Melo JR, Beaven MA, Huang K-P (1989) Differential down-regulation of protein kinase C isozymes. J Biol Chem 264: 4238–4243PubMedGoogle Scholar
  15. 15.
    Ido M, Sekiguchi K, Kikkawa U, Nishizuka Y (1987) Phosphorylation of the EGF receptor from A 431 epidermoid carcinoma cells by three distinct types of protein kinase C. FEBS Lett 219: 215–218PubMedGoogle Scholar
  16. 16.
    Kiley S, Schaap D, Parker P, Hsieh L-L-, Jaken S (1990) Protein kinase C heterogeneity in GH4C1 rat pituitary cells. J Biol Chem 265: 15704–15714PubMedGoogle Scholar
  17. 17.
    Koper JW, Foekens JA, Braakman R, Lamberts SWJ (1990) Effects of progesterone on the response to epidermal growth factor and other growth factors in cultured human meningioma cells. Cancer Res 50: 2604–2607PubMedGoogle Scholar
  18. 18.
    McCaffrey PG, Rosner MR, Kikkawa U, Sekiguchi K, Ogita K, Ase K, Nishizuka Y (1987) Characterization of protein kinase C from normal and transformed cultured murine fibroblasts. Biochem Biophys Res Commun 146: 140–146PubMedGoogle Scholar
  19. 19.
    Melloni E, Pontremoli S, Viotti PL, Patrone M, Marks PA, Rifkind RA (1989) Differential expression of protein kinase C isozymes and erythroleukemia cell differentiation. J Biol Chem 264: 18414–18418PubMedGoogle Scholar
  20. 20.
    Melloni E, Pontremoli S, Sparatore B, Patrone M, Grossi F, Marks PA, Rifkind RA (1990) Introduction of the Β isozyme of protein kinase C accelerates induced differentiation of murine erythroleukemia cells. Proc Natl Acad Sci USA 87: 4417–4420PubMedGoogle Scholar
  21. 21.
    Miñana M-D, Felipo V, Grisolía S (1989) Inhibition of protein kinase C induces differentiation of neuroblastoma cells. FEBS Lett 255: 184–186PubMedGoogle Scholar
  22. 22.
    Miñana M-D, Felipo V, Cortés F, Grisolía S (1991) Inhibition of protein kinase C arrests proliferation of human tumors. FEBS Lett 284: 60–62PubMedGoogle Scholar
  23. 23.
    Naor Z (1990) Further characterization of protein kinase-C sub-species in the hypothalamo-pituitary axis: differential activation by phorbol esters. Endocrinology 126: 1521–1526PubMedGoogle Scholar
  24. 24.
    Nishizuka Y (1984) The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 308: 693–698PubMedGoogle Scholar
  25. 25.
    Nishizuka Y (1989) The family of protein kinase C for signal transduction. JAMA 262: 1826–1833PubMedGoogle Scholar
  26. 26.
    Oda T, Shearman MS, Nishizuka Y (1991) Synaptosomal protein kinase C subspecies: B. Down regulation promoted by phorbol ester and its effect on evoked norepinephrine release. J Neurochem 56: 1263–1269PubMedGoogle Scholar
  27. 27.
    Parodi MT, Varesio L, Tonini GP (1990) The specific inhibitor of protein kinase C, 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine (H 7), induces morphological change and cell differentiation of human neural crest-derived cell lineages. FEBS Lett 269: 4–6PubMedGoogle Scholar
  28. 28.
    Persons DA, Wilkison WO, Bell RM, Finn OJ (1988) Altered growth regulation and enhanced tumorigenicity of NIH 3T3 fibroblasts transfected with protein kinase C-I cDNA, cell 52: 447–458PubMedGoogle Scholar
  29. 29.
    Pollack IF, Randall MS, Kristofik MP, Kelly RH, Selker RG, Vertosick FT (1990) Response of malignant glioma cell lines to activation and inhibition of protein kinase C-mediated pathways. J Neurosurg 73: 98–105PubMedGoogle Scholar
  30. 30.
    Pollack IF, Randal MS, Kristofik MP, Kelly RH, Selker RG, Vertosick FT (1991) Response of low-passage human malignant gliomas in vitro to stimulation and selective inhibition of growth factor-mediated pathways. J Neurosurg 75: 284–293PubMedGoogle Scholar
  31. 31.
    Reifenberger G, Deckert M, Wechsler W (1989) Immunohistochemical determination of protein kinase C expression and proliferative activity in human brain tumors. Acta Neuropathol 78: 166–175PubMedGoogle Scholar
  32. 32.
    Rodriguez-Pena A, Rozengurt E (1984) Disappearance of Ca2+-sensitive, phospholipid-dependent protein kinase activity in phorbol ester-treated 3T3 cells. Biochem Biophys Res Commun 120: 1053–1059PubMedGoogle Scholar
  33. 33.
    Secrist JP, Sehgal I, Powis G, Abraham RT (1990) Preferential inhibition of the platelet-derived growth factor receptor tyrosine kinase by staurosporine. J Biol Chem 265: 20394–20400PubMedGoogle Scholar
  34. 34.
    Shinosawa S, Hachiya T, Hagiwara M, Usuda N, Sugita K, Hidaka H (1990) Type-specific expression of protein kinase C isozymes in CNS tumor cells. Neurosci Lett 108: 11–16PubMedGoogle Scholar
  35. 35.
    Slack RS, Proulx P (1990) Effects of retinoic acid and staurosporine on the protein kinase C activity and the morphology of two related human neuroblastoma cell lines. Biochim Biophys Acta 1053: 89–96PubMedGoogle Scholar
  36. 36.
    Stabel S, Rodriguez-Pena A, Young S, Rozengurt E, Parker PJ (1987) Quantitation of protein kinase C by immunoblot — expression in different cell lines and response to phorbol esters. J Cell Physiol 130: 111–117PubMedGoogle Scholar
  37. 37.
    Strulovici B, Daniel-Issakani S, Oto E, Nestor J Jr, Chan H Tsou A-P (1989) Activation of distinct protein kinase C isozymes by phorbol esters: Correlation with induction of interleukin 1 Β gene expression. Biochemistry 28: 3569–3576PubMedGoogle Scholar
  38. 38.
    Tamaoki T, Nomoto H, Takahashi I, Kato Y, Morimoto M Tomita F (1986) Staurosporine, a potent inhibitor of phospholipid/Ca++ dependent protein kinase. Biochem Biophys Res commun 135: 397–402PubMedGoogle Scholar
  39. 39.
    Todo T, Adams EF, Fahlbusch R (1993) Inhibitory effect of trapidil on human meningioma cell proliferation via interruption of autocrine growth stimulation. J Neurosurg 78: 463–469PubMedGoogle Scholar
  40. 40.
    Todo T, Buchfelder M, Thierauf P, Fahlbusch R (1993) Immunohistochemical expression of protein kinase C type III in human pituitary adenomas. Neurosurgery 32: 635–642PubMedGoogle Scholar
  41. 41.
    Todo T, Fahlbusch R (1994) Accumulation of inositol phosphates in low-passage human meningioma cells by epidermal growth factor. J Neurosurg: in pressGoogle Scholar
  42. 42.
    Todo T, Shitara N, Nakamura H, Takakura K, Tomonaga M, Ikeda protein kinase C isozyme (tape III) in human brain. Brain Res 517: 351–353Google Scholar
  43. 43.
    Todo T, Shitara N, Nakamura H, Takakura K, Ikeda K (1991) Immunohistochemical demonstration of protein kinase C isozymes in human brain tumors. Neurosurgery 29: 399–404PubMedGoogle Scholar
  44. 44.
    Tonini GP, Parodi MT, Martino DD, Veresio L (1991) Expression of protein kinase C-alpha (PKC-α) and MYCN mRNAs in human neuroblastoma cells and modulation during morphological differentiation induced by retinoic acid. FEBS Lett 280: 221–224PubMedGoogle Scholar
  45. 45.
    Tsuda M, Ono K, Katayama N, Yamagata Y, Kikuchi K, Tsuchiya T (1989) Neurite outgrowth from mouse neuroblastoma and cerebellar cells induced by the protein kinase inhibitor H-7. Neurosci Lett 105: 241–245PubMedGoogle Scholar
  46. 46.
    Wada H, Ohno S, Kubo K, Taya C, Tsuji S, Yonehara S, Suzuki K (1989) Cell type-specific expression of the genes for the protein kinase C family: down regulation of mRNAs for PKCα and nPKCε upon in vitro differentiation of a mouse neuroblastoma cell line neuro 2 a. Biochem Biophys Res Commun 165: 533–538PubMedGoogle Scholar
  47. 47.
    Weisman AS, Villemure J-G, Kelly PA (1986) Regulation of DNA synthesis and growth of cells derived from primary human meningiomas. Cancer Res 46: 2545–2550PubMedGoogle Scholar
  48. 48.
    Young S, Parker PJ, Ullrich A, Stabel S (1987) Down-regulation of protein kinase C is due to an increased rate of degradation. Biochem J 244: 775–779PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • T. Todo
    • 1
  • R. Fahlbusch
    • 2
  1. 1.Department of NeurosurgeryInternational Medical Center of JapanTokyoJapan
  2. 2.Department of NeurosurgeryUniversity of Erlangen-NürnbergErlangenFederal Republic of Germany

Personalised recommendations